A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)

Intensive combined therapy including modification of the lifestyle, intake of metformin and/or sulfonylureas, insulin treatment in the absence ofadequate HbAc1 control, hypolipidemic, early antihypertensive and antithrombotic therapy not only decreases the frequency of DM2 complicationsbut also redu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Yury Shavkatovich Khalimov, Alla Vsevolodovna Rudakova
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2011
Materias:	steno-2 diabetes mellitus gliclazide Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/054ce88c5fff4e6dadc21c6fbb38b1e6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:054ce88c5fff4e6dadc21c6fbb38b1e6
record_format	dspace
spelling	oai:doaj.org-article:054ce88c5fff4e6dadc21c6fbb38b1e62021-11-14T09:00:16ZA cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)2072-03512072-037810.14341/2072-0351-5647https://doaj.org/article/054ce88c5fff4e6dadc21c6fbb38b1e62011-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5647https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Intensive combined therapy including modification of the lifestyle, intake of metformin and/or sulfonylureas, insulin treatment in the absence ofadequate HbAc1 control, hypolipidemic, early antihypertensive and antithrombotic therapy not only decreases the frequency of DM2 complicationsbut also reduces the total cost of the treatment (1.8 times compared with traditional therapy). Reduction in cardiovascular mortality achieved inSTENO-2 was due to intense control of risk factors at early stages of therapy with the use of modified release gliclazide (Diabeton MV). This treatmentis considered to be not only more efficacious than routine therapy but also to significantly reduce the cost of the management of DM2Yury Shavkatovich KhalimovAlla Vsevolodovna RudakovaEndocrinology Research Centrearticlesteno-2diabetes mellitussteno-2gliclazideNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 14, Iss 2, Pp 116-120 (2011)
institution	DOAJ
collection	DOAJ
language	EN RU
topic	steno-2 diabetes mellitus steno-2 gliclazide Nutritional diseases. Deficiency diseases RC620-627
spellingShingle	steno-2 diabetes mellitus steno-2 gliclazide Nutritional diseases. Deficiency diseases RC620-627 Yury Shavkatovich Khalimov Alla Vsevolodovna Rudakova A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
description	Intensive combined therapy including modification of the lifestyle, intake of metformin and/or sulfonylureas, insulin treatment in the absence ofadequate HbAc1 control, hypolipidemic, early antihypertensive and antithrombotic therapy not only decreases the frequency of DM2 complicationsbut also reduces the total cost of the treatment (1.8 times compared with traditional therapy). Reduction in cardiovascular mortality achieved inSTENO-2 was due to intense control of risk factors at early stages of therapy with the use of modified release gliclazide (Diabeton MV). This treatmentis considered to be not only more efficacious than routine therapy but also to significantly reduce the cost of the management of DM2
format	article
author	Yury Shavkatovich Khalimov Alla Vsevolodovna Rudakova
author_facet	Yury Shavkatovich Khalimov Alla Vsevolodovna Rudakova
author_sort	Yury Shavkatovich Khalimov
title	A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
title_short	A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
title_full	A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
title_fullStr	A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
title_full_unstemmed	A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)
title_sort	cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of steno-2 study)
publisher	Endocrinology Research Centre
publishDate	2011
url	https://doaj.org/article/054ce88c5fff4e6dadc21c6fbb38b1e6
work_keys_str_mv	AT yuryshavkatovichkhalimov acosteffectivenessanalysisofintensivetherapyoftype2diabetesmellitusresultsofsteno2study AT allavsevolodovnarudakova acosteffectivenessanalysisofintensivetherapyoftype2diabetesmellitusresultsofsteno2study AT yuryshavkatovichkhalimov costeffectivenessanalysisofintensivetherapyoftype2diabetesmellitusresultsofsteno2study AT allavsevolodovnarudakova costeffectivenessanalysisofintensivetherapyoftype2diabetesmellitusresultsofsteno2study
_version_	1718429569127546880

A cost-effectiveness analysis of intensive therapy of type 2 diabetes mellitus (results of Steno-2 study)

Ejemplares similares